MedPath

MIFEGYMISO

MIFEGYMISO

Approved
DIN Number

02444038

Drug Class

Human

Market Date

Jan 10, 2017

Company
HC

linepharma international limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02444038
AIG Number0257170001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03XB51 MIFEPRISTONE, COMBINATIONS
Product Specifications
Dosage FormTablet ,  Kit
Route of AdministrationBuccal ,  Oral
AHFS Classification56:28.28
Health Canada Classification

ACTIVE INGREDIENTS (2)

MIFEPRISTONEActive
Strength: 200 MG
Monograph: MIFEPRISTONE
MISOPROSTOLActive
Strength: 200 MCG
Monograph: MISOPROSTOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.